Version history

{
  "session_id": "sess_SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf_task_9aae8fc5",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "# Critical Evaluation of TDP-43 Pathology Hypotheses\n\n---\n\n## Hypothesis 1: Aβ42 → CDK5/p25 → TDP-43 Phosphorylation\n\n### Weak Links\n\n| Issue | Problem |\n|-------|---------|\n| **Specificity paradox** | CDK5 is ubiquitously expressed in neurons. If Aβ42→CDK5→pTDP-43 is the mechanism, why don't motor neurons with any Aβ exposure show limbic-pattern pathology? The hypothesis lacks a cell-type-specific amplifier explaining regional susceptibility. |\n| **Causality ambiguity** | Aβ42-induced CDK5 activation (PMID 28794024) may represent general proteostatic stress response, not a specific pathogenic cascade. CDK5 hyperactivation occurs in many neurodegenerative conditions. |\n| **Epitope claim unsubstantiated** | S409/410 phosphorylation is the predominant epitope in *both* AD and ALS. The hypothesis asserts \"AD-specific phospho-epitopes\" and \"distinct electrophoretic patterns\" without citing evidence differentiating them. |\n| **LATE-NC counter-evidence** | Limbic-predominant age-related TDP-43 proteinopathy (LATE) occurs in elderly without significant amyloid pathology, indicating TDP-43 can aggregate independently of Aβ. |\n\n### Falsifying Experiment\nPerform **phosphoproteomics on cases with high TDP-43 burden but minimal Aβ** (e.g., LATE-NC, primary FTLD). If CDK5/p25 drives AD-specific phosphorylation, these cases should show absent/reduced pS409/410 burden. Finding comparable phosphorylation would refute disease-specific kinase involvement.\n\n### Revised Confidence: **0.58**\n*Downgraded due to weak epitope specificity claim, absence of mechanistic explanation for regional selectivity, and counter-examples of Aβ-independent TDP-43 pathology.*\n\n---\n\n## Hypothesis 2: KPNA2 Downregulation → Nuclear Import Deficit\n\n### Weak Links\n\n| Issue | Problem |\n|-------|---------|\n| **Epigenetic mechanism unsupported** | The hypothesis invokes \"oxidative damage to NF-κB binding sites in the KPNA2 promoter\" without citing any evidence this occurs in aging limbic neurons. This is speculative scaffolding. |\n| **Redundant import machinery** | KPNA2 is one of 7 importin-α isoforms. Neurons express multiple family members (KPNA1, KPNA3, KPNA4) that can compensate. Knockdown of a single importin rarely abolishes nuclear import completely. |\n| **Motor neuron vulnerability unexplained** | If ALS/FTLD \"retains normal limbic KPNA2,\" why do motor neurons develop TDP-43 pathology? The hypothesis fails to explain the *positive* driver in ALS and merely notes absence of the AD-specific factor. |\n| **Consequence vs. cause** | KPNA2 downregulation in aged hippocampus (PMID 28847786) may be a *downstream effect* of neuronal loss and glial activation, not a primary driver. |\n| **snRNA-seq prediction is circular** | The \"predicted finding\" of limbic-specific importin downregulation in AD is what the experiment would test—but this finding, if present, still wouldn't establish causality. |\n\n### Falsifying Experiment\nPerform **KPNA2 CRISPR knockout in young (3-month) mice** for 12 months. If importin downregulation is the primary driver, young mice with complete KPNA2 loss should develop spontaneous hippocampal TDP-43 pathology. Absence of pathology would indicate KPNA2 loss is insufficient without additional age-related co-factors—or that compensatory isoforms prevent pathology.\n\n### Revised Confidence: **0.52**\n*Downgraded because the causal chain relies on an undocumented epigenetic mechanism, ignores importin redundancy, and cannot explain ALS motor neuron vulnerability.*\n\n---\n\n## Hypothesis 3: circPDS5B → miR-497-5p → TDP-43 Translation Overload\n\n### Weak Links\n\n| Issue | Problem |\n|-------|---------|\n| **circRNA evidence is correlative** | Cited GEO datasets showing circPDS5B downregulation do not establish causality. Global circRNA dysregulation is common in neurodegeneration; most changes are epiphenomena. |\n| **ceRNA specificity implausible** | Individual circRNAs typically sponge multiple miRNAs; the hypothesis requires circPDS5B to be specifically \"the\" regulator of miR-497-5p/TARDBP without evidence of preferential interaction. |\n| **TDP-43 autoregulation conflict** | TDP-43 negatively autoregulates its own mRNA through binding to the",
  "tokens_used": "1045",
  "persona_id": "persona-skeptic"
}